Table 7.
Patient groups | Upper lip | Anterior palate | Posterior palate | Inside cheeks | Lower lip | Anterior tongue | Posterior tongue | Floor mouth |
---|---|---|---|---|---|---|---|---|
XI total for controls | 0.57 (0.43–0.69)** | 0.66 (0.53–0.77)** | 0.66 (0.54–0.75)** | 0.54 (0.38–0.68)** | 0.51 (0.36–0.64)** | 0.61 (0.48–0.71)** | 0.61 (0.48–0.70)** | 0.49 (0.33–0.63)** |
XI total for Low Med patients | 0.43 (0.25–0.58)** | 0.43 (0.29–0.57)** | 0.47 (0.29–0.62)** | 0.52 (0.36–0.67)** | 0.47 (0.30–0.62)** | 0.58 (0.46–0.68)** | 0.56 (0.42–0.68)** | 0.48 (0.30–0.65)** |
XI total for High Med patients | 0.56 (0.39–0.70** | 0.64 (0.52–0.75)** | 0.62 (0.46–0.75)** | 0.61 (0.46–0.73)** | 0.51 (0.34–0.66)** | 0.52 (0.34–0.67)** | 0.59 (0.44–0.72)** | 0.56 (0.41–0.70)** |
XI total for RTX patients | NS | 0.69 (0.12–0.98)* | NS | NS | NS | 0.70 (0.00–1.00)* | 0.78 (0.11–1.00)* | NS |
XI total for SS patients | NS | 0.48 (0.14–0.76)** | 0.66 (0.46–0.82)** | 0.48 (0.15–0.74)** | 0.34 (−0.01–0.62)* | 0.68 (0.47–0.83)** | 0.58 (0.30–0.79)** | 0.56 (0.24–0.81)** |
XI total for SS + High Med patients | 0.59 (0.14–0.88)* | NS | NS | 0.57 (0.04–0.90)* | 0.57 (0.07–0.87)* | NS | NS | 0.63 (0.07–0.88)** |
NS not significant
The Spearman’s rho correlation coefficient is shown with the bias-corrected accelerated (BCa) 95% confidence interval
* indicates that that the correlation is significant at level 0.05
** indicates that that the correlation is significant at level 0.01